Evolent Health (EVH) Free Cash Flow (2015 - 2026)

Evolent Health has reported Free Cash Flow for 12 years, with the latest figure at -$16.2 million in Q2 2026.

• On a quarterly basis, Free Cash Flow rose 58.67% year-over-year to -$16.2 million in Q2 2026; TTM through Jun 2026 was $24.3 million, a 138.55% increase from a year earlier, with the FY2025 full-year figure at $4.8 million, up 177.59% from the prior year.
• Free Cash Flow was -$16.2 million for Q2 2026 at Evolent Health, down from -$7.4 million in the prior quarter.
• The five-year high for Free Cash Flow was $83.3 million in Q4 2023, with the low at -$66.0 million in Q1 2022.
• Average Free Cash Flow over 5 years is $2.2 million, with a median of -$2.2 million recorded in 2024.
• The sharpest annual moves came in 2023 and 2025: Free Cash Flow surged 502.64% in 2023, then plunged 820.09% in 2025.
• Over 5 years, Free Cash Flow stood at $25.0 million in 2022, then surged by 233.96% to $83.3 million in 2023, then slumped by 138.86% to -$32.4 million in 2024, then surged by 226.73% to $41.0 million in 2025, then tumbled by 139.38% to -$16.2 million in 2026.
• The last three Free Cash Flow figures came in at -$16.2 million (Q2 2026), -$7.4 million (Q1 2026), and $41.0 million (Q4 2025), per Business Quant data.